- Global Pharma News & Resources

Calciphylaxis Treatment Market 2021 : Take Advantage and Grow – Read These Few Tips

The Calciphylaxis Treatment Market report presents the global Calciphylaxis Treatment sales and revenue by companies, regions, type and application and forecast to 2027. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

Request Here For PDF Brochure

Calcific Uremic Arteriolopathy (CUA) and Calciphylaxis is the most serious type of cardiovascular calcification in patients of dialysis. It begins with a small peripheral vessel calcification and rapidly spreads within the body. Furthermore, people enduring from calciphylaxis endure an imbalance in the metabolism of calcium, which causes deposition of calcium in the arterioles, eventually leading to blood clot formations within the arterioles. Blood clots could lead to oxygen and nourishment deprivation of skin and fat tissues.

As per the National Center for Biotechnology Information (NCBI) published 2014 report, calciphylaxis infects around 4% patients in final stages of chronic kidney diseases, with 55% of calciphylaxis patients die within just one year of diagnosis and endure from high infection risk and painful ulcers of skin. No potent treatment of calciphylaxis is presently available, along with its unknown causes. However, patients having this condition are generally treated with wound management, along with intensive care. The calciphylaxis occurrence is related to hyperthyroidism.

The global calciphylaxis treatment market size accounted for US$ 1,097.7 million in 2017 and is projected to exhibit a CAGR of 9.6% over the forecast period (2018 – 2026).

Global Calciphylaxis Treatment Market: Drivers

Rising clinical trials within the calciphylaxis field is expected to propel the global calciphylaxis treatment market growth in the near future.

As per the 2014 study from the Journal of General Internal Medicine, prevalence of calciphylaxis increasing, with the mortality rate of 50% within the onset’s first year. High kidney disease incidence is a key factor calciphylaxis incidences. As per the National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center, above 661,000 people in the U.S. suffered from kidney failure, where 468,000 patients among these were on a dialysis, in 2016.

Several companies and academic research institutes are focusing on development of suitable calciphylaxis treatment. For instance, Sanifit, in March 2018, successfully completed its trial for Phase II for calciphylaxis’s first treatment that is effective. Furthermore, in 2014, scientists from the National Kidney Foundation registered successful intravenous (IV) pamidronate application for treating calciphylaxis within patients having End-Stage Renal Disease (ESRD).

Global Calciphylaxis Treatment Market: Restraints

Absence of adequate calciphylaxis treatment is a key factor restraining the global calciphylaxis treatment market growth over the forecast period. However, rising research for developing an appropriate treatment for this disorder is expected to propel the market growth.

Global Calciphylaxis Treatment Market: Regional Insights

Based on geography, the global calciphylaxis treatment market is segregated into North America, Europe, Latin America, Asia Pacific, Africa and Middle East. North America is expected to generate significant revenue share in the global calciphylaxis treatment market, due to rising government funding and support for treating patients of calciphylaxis. As per the 2015 study from the National Kidney Disease Education Program, in the U.S., chronic kidney diseases treatment values for US$ 48 Bn, in the U.S. every year, where the ESRD program occupies 6.7% of entire budget of Medicare care for below 1% of population covered.

Asia Pacific is expected to register robust growth, due to rising treatment expenditure for kidney diseases combined with high kidney disease with diabetes prevalence and increasing base of geriatric population. For instance, as per 2015 study by the National Kidney Disease Education Program, treatment of entire new and current kidney failure cases is expected to account for above US$ 12 Bn, in Australia, by 2020. Furthermore, the annual dialysis cost per patient, varies from US $35,000 to 55,000 relying upon treatment type.

Major Key Players Include In Calciphylaxis Treatment Market: 3M, Amgen Inc., BSN Medical, ConvaTec Inc., Medtronic Plc., Smith & Nephew Plc., and Laboratoris Sanifit S.L.

Buy instant copy of this research report with Flat US $ 2000 Off@ –

Main points in Calciphylaxis Treatment Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Calciphylaxis Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Calciphylaxis Treatment Industry Impact

Chapter 2 Global Calciphylaxis Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Calciphylaxis Treatment (Volume and Value) by Type
2.3 Global Calciphylaxis Treatment (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Calciphylaxis Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Calciphylaxis Treatment Market Analysis
Chapter 6 East Asia Calciphylaxis Treatment Market Analysis
Chapter 7 Europe Calciphylaxis Treatment Market Analysis
Chapter 8 South Asia Calciphylaxis Treatment Market Analysis
Chapter 9 Southeast Asia Calciphylaxis Treatment Market Analysis
Chapter 10 Middle East Calciphylaxis Treatment Market Analysis
Chapter 11 Africa Calciphylaxis Treatment Market Analysis
Chapter 12 Oceania Calciphylaxis Treatment Market Analysis
Chapter 13 South America Calciphylaxis Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Calciphylaxis Treatment Business
Chapter 15 Global Calciphylaxis Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Request for a Sample Report 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 23-Aug-2021